Welcome to LookChem.com Sign In|Join Free
  • or
3-(3-oxo-1-phenylbutyl)-4-sodiooxy-2H-1-benzopyran-2-one is a complex organic compound with a molecular formula of C20H15NaO4. It is a derivative of 2H-1-benzopyran-2-one, which is a type of chromone. 3-(3-oxo-1-phenylbutyl)-4-sodiooxy-2H-1-benzopyran-2-one features a benzopyran core with a 3-oxo-1-phenylbutyl side chain and a sodium atom attached to the 4-oxygen atom. The presence of the sodium atom indicates that it is a salt form of the compound, which can be useful in various chemical reactions and applications. The structure of 3-(3-oxo-1-phenylbutyl)-4-sodiooxy-2H-1-benzopyran-2-one is characterized by its aromatic ring system, carbonyl groups, and the sodium atom, which together contribute to its unique chemical properties and potential applications in fields such as pharmaceuticals, materials science, and organic synthesis.

5543-79-3

Post Buying Request

5543-79-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5543-79-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5543-79-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,5,4 and 3 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 5543-79:
(6*5)+(5*5)+(4*4)+(3*3)+(2*7)+(1*9)=103
103 % 10 = 3
So 5543-79-3 is a valid CAS Registry Number.

5543-79-3Upstream product

5543-79-3Downstream Products

5543-79-3Relevant academic research and scientific papers

PROCESS FOR SYNTHESIS OF PURE WARFARIN ACID, WARFARIN ALKALI METAL SALTS AND CORRESPONDING CLATHRATES

-

, (2008/06/13)

An improved procedure for the purification of warfarin acid. Sodium, potassium and lithium warfarin salts and the corresponding clathrates are prepared in high, pharmacopeial grade purity and good yields from the pure warfarin acid and the respective metal salt bases in suitable media.

Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate

-

, (2008/06/13)

The present invention is a method for producing warfarin sodium from warfarin sodium 2-propanol clathrate by thermal, nondestructive solvent expulsion. The solvent expulsion is conducted under conditions of controlled heat transfer whereby the 2-propanol is expelled from the warfarin sodium 2-propanol clathrate without decomposition of warfarin sodium or the clathrate. Heating is conducted the clathrate at a temperature from about 100° C. to about 170° C. in an active oven under air or in an inert atmosphere and at partial pressures ranging from that of a relative vacuum to atmospheric pressure. The invention also relates to pure warfarin sodium prepared according to the method of the invention and pharmaceutical compositions containing warfarin sodium.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5543-79-3